Diabetic foot disease is associated with reduced erythrocyte deformability

International Wound Journal

Volumn 13, Issue 4, 2016, Pages 500-504

  Cahn, Avivit ^a   Livshits, Leonid ^a   Srulevich, Ariel ^a   Raz, Itamar ^a   Yedgar, Shaul ^a   Barshtein, Gregory ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cell flow analyser; Diabetic foot; Erythrocyte deformability

Indexed keywords

ADULT; ARTICLE; CAPILLARY FLOW; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; ERYTHROCYTE DEFORMABILITY; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MICROVASCULATURE; PRIORITY JOURNAL; ERYTHROCYTE; FLOW KINETICS; NON INSULIN DEPENDENT DIABETES MELLITUS;

DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; RHEOLOGY;

EID: 84930317085     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/iwj.12466     Document Type: Article

References (24)

1. Bakker K, Schaper NC, International Working Group on Diabetic Foot Editorial Board. The development of global consensus guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 2012;28(Suppl 1):116–8.
2. Chao CY, Cheing GL. Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev 2009;25:604–14.
3. Dinh T, Veves A. Microcirculation of the diabetic foot. Curr Pharm Des 2005;11:2301–9.
4. Raskin P, Pietri AO, Unger R, Shannon WA Jr. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with Type I diabetes mellitus. N Engl J Med 1983;309:1546–50.
5. Fagrell B, Jörneskog G, Intaglietta M. Disturbed microvascular reactivity and shunting – a major cause for diabetic complications. Vasc Med 1999;4:125–7.
6. Giansanti R, Boemi M, Rabini RA, Amodio L, Fioravanti P, Romagnoli F, Fumelli P. Haemorheological profile and retinopathy in patients with diabetic foot ulcer. Clin Hemorheol Microcirc 1995;15:73–80.
7. Mantskava M, Momtselidze N, Pargalava N, Mchedlishvili G. Hemorheological disorders in patients with type 1 or 2 diabetes mellitus and foot gangrene. Clin Hemorheol Microcirc 2006;35:307–10.
8. Barshtein G, Manny N, Yedgar S. Circulatory risk in the transfusion of red blood cells with impaired flow properties induced by storage. Transfus Med Rev 2011;25:24–35.
9. Relevy H, Koshkaryev A, Manny N, Yedgar S, Barshtein G. Blood banking-induced alteration of red blood cell flow properties. Transfusion 2008;48:136–46.
10. Livshits L, Srulevich A, Raz I, Cahn A, Barshtein G, Yedgar S, Eldor R. Effect of short-term hyperglycemia on protein kinase C alpha activation in human erythrocytes. Rev Diabet Stud 2012;9:94–103.
11. Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol 2008;2:1130–8.
12. Kaul DK, Koshkaryev A, Artmann G, Barshtein G, Yedgar S. Additive effect of red blood cell rigidity and adherence to endothelial cells in inducing vascular resistance. Am J Physiol 2008;295:H1788–93.
13. Matot I, Katz M, Pappo O, Zelig O, Corchia N, Yedgar S, Barshtein G, Bennett-Guerrero E, Abramovitch R. Resuscitation with aged blood exacerbates liver injury in a hemorrhagic rat model. Crit Care Med 2013;41:842–9.
14. Singh M, Shin S. Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review. Indian J Exp Biol 2009;47:7–15.
15. Shin S, Ku YH, Ho JX, Kim YK, Suh JS, Singh M. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin Hemorheol Microcirc 2007;36:253–61.
16. Koscielny J, Latza R, Wolf S, Kiesewetter H, Jung F. Early rheological and microcirculatory changes in children with type I diabetes mellitus. Clin Hemorheol Microcirc 1998;19:139–50.
17. Lippi G, Mercadanti M, Aloe R, Targher G. Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. Eur J Intern Med 2012;23:150–3.
18. Buys AV, Van Rooy MJ, Soma P, Van Papendorp D, Lipinski B, Pretorius E. Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc Diabetol 2013;12:25.
19. Gyawali P, Richards RS, Uba NE. Erythrocyte morphology in metabolic syndrome. Expert Rev Hematol 2012;5:523–31.
20. Hu H, Jiang H, Ren H, Hu X, Wang X, Han C. AGEs and chronic subclinical inflammation in diabetes: disorders of immune system. Diabetes Metab Res Rev 2015;31:127–37.
21. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, Nowygrod S, Wolf BM, Caliste X, Yan SF, Stern DM, Schmidt AM. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001;159:513–25.
22. Condon MR, Kim JE, Deitch EA, Machiedo GW, Spolarics Z. Appearance of an erythrocyte population with decreased deformability and hemoglobin content following sepsis. Am J Physiol Heart Circ Physiol 2003;284:H2177–84.
23. Schwartz RS, Madsen JW, Rybicki AC, Nagel RL. Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes 1991;40:701–8.
24. Garnier M, Attali JR, Valensi P, Delatour-Hanss E, Gaudey F, Koutsouris D. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism 1990;39:794–8.